| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,397 |
10,609 |
$241K |
| 99223 |
Prolong inpt eval add15 m |
991 |
892 |
$175K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,821 |
23,883 |
$148K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,370 |
1,353 |
$109K |
| 99215 |
Prolong outpt/office vis |
890 |
806 |
$100K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,396 |
810 |
$89K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,354 |
541 |
$70K |
| E1390 |
Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate |
606 |
545 |
$65K |
| S9083 |
Global fee urgent care centers |
1,310 |
1,216 |
$63K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
795 |
126 |
$57K |
| 20553 |
|
510 |
474 |
$34K |
| 97039 |
|
991 |
374 |
$33K |
| E0601 |
Continuous positive airway pressure (cpap) device |
354 |
352 |
$29K |
| 97803 |
|
1,274 |
1,127 |
$28K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,053 |
5,910 |
$28K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,129 |
5,979 |
$27K |
| 99233 |
Prolong inpt eval add15 m |
1,085 |
335 |
$26K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
713 |
710 |
$23K |
| 99205 |
Prolong outpt/office vis |
145 |
145 |
$21K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
524 |
524 |
$21K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
357 |
252 |
$20K |
| 97802 |
|
489 |
457 |
$19K |
| T4541 |
Incontinence product, disposable underpad, large, each |
946 |
945 |
$17K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
142 |
132 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,895 |
1,033 |
$16K |
| T4535 |
Disposable liner/shield/guard/pad/undergarment, for incontinence, each |
574 |
573 |
$15K |
| 92552 |
|
1,067 |
1,030 |
$14K |
| K0001 |
Standard wheelchair |
295 |
292 |
$14K |
| 92551 |
|
2,820 |
2,772 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
508 |
472 |
$11K |
| 99221 |
|
494 |
457 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
22,052 |
18,459 |
$11K |
| 95117 |
|
1,115 |
292 |
$10K |
| 81025 |
|
472 |
456 |
$10K |
| E0443 |
Portable oxygen contents, gaseous, 1 month's supply = 1 unit |
206 |
206 |
$10K |
| 81000 |
|
829 |
730 |
$10K |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
370 |
369 |
$10K |
| V2020 |
Frames, purchases |
398 |
398 |
$8K |
| 80053 |
Comprehensive metabolic panel |
19,495 |
17,847 |
$8K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
628 |
559 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
463 |
175 |
$7K |
| E0431 |
Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing |
401 |
398 |
$7K |
| 81002 |
|
1,041 |
755 |
$7K |
| 95144 |
|
45 |
44 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
582 |
568 |
$6K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
199 |
184 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
593 |
580 |
$6K |
| 92340 |
Fitting of spectacles, except for aphakia; monofocal |
269 |
269 |
$6K |
| 92015 |
Determination of refractive state |
706 |
705 |
$6K |
| 93000 |
|
397 |
389 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
754 |
710 |
$5K |
| 90686 |
|
837 |
837 |
$5K |
| 97162 |
|
103 |
103 |
$5K |
| 11721 |
|
153 |
149 |
$5K |
| A4649 |
Surgical supply; miscellaneous |
228 |
175 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
424 |
307 |
$4K |
| 97014 |
|
260 |
105 |
$4K |
| 99173 |
|
1,764 |
1,753 |
$4K |
| 99000 |
|
4,028 |
3,847 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
55 |
54 |
$4K |
| 59425 |
|
156 |
94 |
$4K |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
243 |
243 |
$3K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
43 |
43 |
$3K |
| 76857 |
|
74 |
67 |
$3K |
| 99222 |
Initial hospital care, per day, moderate complexity |
55 |
53 |
$3K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
47 |
45 |
$3K |
| 85018 |
|
1,958 |
1,933 |
$3K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
66 |
66 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,119 |
1,998 |
$3K |
| 99152 |
|
13 |
13 |
$3K |
| 20610 |
|
38 |
24 |
$3K |
| 62323 |
|
26 |
25 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
44 |
42 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,685 |
5,124 |
$2K |
| 92133 |
|
108 |
108 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
403 |
392 |
$2K |
| 51798 |
|
138 |
131 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,195 |
1,187 |
$2K |
| T4527 |
Adult sized disposable incontinence product, protective underwear/pull-on, large size, each |
26 |
26 |
$2K |
| 92083 |
|
108 |
108 |
$2K |
| 82948 |
|
1,546 |
992 |
$2K |
| A4335 |
Incontinence supply; miscellaneous |
216 |
216 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,859 |
9,720 |
$2K |
| 92250 |
|
40 |
39 |
$2K |
| 80061 |
Lipid panel |
12,727 |
12,641 |
$2K |
| 88150 |
|
63 |
63 |
$2K |
| 71045 |
Radiologic examination, chest; single view |
195 |
163 |
$2K |
| 81001 |
|
9,230 |
8,946 |
$2K |
| 84484 |
|
1,368 |
1,122 |
$2K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
134 |
128 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
12,204 |
11,551 |
$1K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
55 |
53 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
314 |
226 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,407 |
10,308 |
$1K |
| 85610 |
|
2,311 |
2,013 |
$1K |
| 92081 |
|
1,206 |
1,203 |
$1K |
| 94150 |
|
222 |
92 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,922 |
3,904 |
$1K |
| 90651 |
|
209 |
209 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
367 |
367 |
$1K |
| 72275 |
|
55 |
54 |
$1K |
| 85730 |
|
1,553 |
1,369 |
$1K |
| 90670 |
|
168 |
168 |
$1K |
| 83735 |
|
1,120 |
798 |
$985.53 |
| 83880 |
|
375 |
329 |
$966.49 |
| 90715 |
|
119 |
118 |
$899.90 |
| 83690 |
|
1,096 |
986 |
$896.25 |
| T4528 |
Adult sized disposable incontinence product, protective underwear/pull-on, extra large size, each |
12 |
12 |
$872.45 |
| E0143 |
Walker, folding, wheeled, adjustable or fixed height |
12 |
12 |
$840.40 |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
13 |
13 |
$782.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
1,263 |
1,259 |
$778.36 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
152 |
120 |
$720.30 |
| 99199 |
Unlisted special service, procedure or report |
22 |
21 |
$718.27 |
| 90734 |
|
112 |
112 |
$669.84 |
| 99442 |
|
6,084 |
5,540 |
$636.32 |
| 1036F |
|
3,650 |
3,430 |
$596.62 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
16 |
14 |
$566.64 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,572 |
2,470 |
$553.55 |
| J3490 |
Unclassified drugs |
37 |
24 |
$551.17 |
| G2010 |
Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment |
52 |
43 |
$547.39 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,032 |
4,012 |
$546.16 |
| 90647 |
|
31 |
31 |
$530.76 |
| 90723 |
|
14 |
14 |
$513.98 |
| 85027 |
|
1,689 |
1,552 |
$503.40 |
| 81003 |
|
1,722 |
1,631 |
$492.12 |
| 3008F |
|
6,721 |
6,188 |
$487.69 |
| 86003 |
|
234 |
233 |
$472.27 |
| 92020 |
|
25 |
25 |
$456.76 |
| 82570 |
|
2,964 |
2,928 |
$438.69 |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12 |
12 |
$434.55 |
| 86803 |
|
1,205 |
1,204 |
$430.61 |
| 90658 |
|
174 |
174 |
$385.92 |
| 3079F |
|
580 |
534 |
$368.84 |
| 80076 |
|
589 |
485 |
$352.56 |
| 4004F |
|
149 |
131 |
$338.47 |
| A7038 |
Filter, disposable, used with positive airway pressure device |
54 |
53 |
$334.68 |
| 1111F |
|
2,400 |
1,955 |
$323.18 |
| 3078F |
|
4,604 |
4,316 |
$323.11 |
| 82550 |
|
567 |
528 |
$319.42 |
| 90633 |
|
77 |
77 |
$312.04 |
| A7035 |
Headgear used with positive airway pressure device |
12 |
12 |
$296.71 |
| 3077F |
|
564 |
471 |
$272.05 |
| 90621 |
|
31 |
31 |
$272.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
330 |
330 |
$269.83 |
| A7037 |
Tubing used with positive airway pressure device |
12 |
12 |
$265.88 |
| 83605 |
|
134 |
92 |
$265.53 |
| 82728 |
|
720 |
712 |
$264.79 |
| 85007 |
|
283 |
195 |
$232.55 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
128 |
59 |
$228.93 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
95 |
27 |
$225.27 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
689 |
683 |
$225.04 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,354 |
1,302 |
$221.51 |
| 80074 |
|
778 |
776 |
$215.72 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
542 |
540 |
$207.00 |
| 90656 |
|
101 |
101 |
$203.30 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
62 |
57 |
$197.10 |
| 84550 |
|
1,446 |
1,429 |
$189.62 |
| 1160F |
|
1,158 |
1,047 |
$189.40 |
| 51741 |
|
15 |
14 |
$187.50 |
| 86580 |
|
59 |
58 |
$182.85 |
| 84439 |
|
1,987 |
1,961 |
$161.83 |
| 86900 |
|
291 |
270 |
$155.13 |
| 84100 |
|
638 |
562 |
$154.72 |
| 87081 |
|
324 |
316 |
$141.73 |
| 86431 |
|
768 |
765 |
$140.55 |
| 83540 |
|
974 |
959 |
$137.07 |
| 82607 |
|
1,090 |
1,087 |
$136.88 |
| 82043 |
|
2,906 |
2,890 |
$134.89 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
133 |
116 |
$134.09 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
41 |
36 |
$131.95 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
185 |
185 |
$128.18 |
| 86140 |
|
973 |
952 |
$120.98 |
| 83550 |
|
755 |
745 |
$120.17 |
| 84155 |
|
191 |
95 |
$112.50 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
239 |
235 |
$111.88 |
| 86592 |
|
4,421 |
4,379 |
$111.66 |
| 3080F |
|
359 |
305 |
$109.20 |
| 36410 |
|
76 |
76 |
$108.60 |
| 90700 |
|
12 |
12 |
$108.00 |
| 3074F |
|
4,469 |
4,216 |
$103.74 |
| 82746 |
|
794 |
790 |
$102.01 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
107 |
104 |
$100.75 |
| 84703 |
|
305 |
293 |
$99.00 |
| 84436 |
|
1,566 |
1,559 |
$97.39 |
| 84702 |
|
412 |
363 |
$95.31 |
| 86901 |
|
206 |
186 |
$91.02 |
| 87340 |
|
1,005 |
1,001 |
$90.47 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
15 |
14 |
$83.75 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
201 |
200 |
$81.00 |
| 86038 |
|
1,188 |
1,177 |
$79.88 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
1,421 |
1,415 |
$79.75 |
| 87186 |
|
459 |
452 |
$78.16 |
| 84153 |
|
946 |
931 |
$74.18 |
| 83655 |
|
787 |
786 |
$72.58 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
319 |
295 |
$70.64 |
| 83721 |
|
379 |
379 |
$68.99 |
| 87040 |
|
65 |
55 |
$66.65 |
| 87077 |
|
442 |
435 |
$65.42 |
| 92134 |
|
25 |
25 |
$64.50 |
| 86850 |
|
46 |
45 |
$60.25 |
| 90461 |
|
199 |
199 |
$54.00 |
| 84479 |
|
910 |
909 |
$49.87 |
| 86706 |
|
747 |
747 |
$49.49 |
| 96127 |
|
399 |
339 |
$40.81 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
127 |
110 |
$38.26 |
| 82378 |
|
93 |
87 |
$37.73 |
| 87088 |
|
1,594 |
1,546 |
$37.25 |
| 86235 |
|
107 |
106 |
$35.50 |
| 99348 |
|
37 |
37 |
$34.30 |
| 83615 |
|
38 |
36 |
$28.37 |
| 84481 |
|
850 |
843 |
$28.23 |
| 83001 |
|
272 |
271 |
$28.00 |
| 82140 |
|
14 |
13 |
$27.72 |
| 86480 |
|
282 |
281 |
$27.52 |
| 87070 |
|
512 |
509 |
$27.47 |
| 82248 |
|
786 |
780 |
$27.05 |
| 83026 |
|
31 |
31 |
$27.00 |
| 85652 |
|
1,384 |
1,359 |
$26.58 |
| 1157F |
|
34 |
31 |
$24.00 |
| 82785 |
|
147 |
146 |
$23.21 |
| 86704 |
|
651 |
651 |
$22.53 |
| 86039 |
|
313 |
308 |
$22.21 |
| Q0111 |
Wet mounts, including preparations of vaginal, cervical or skin specimens |
50 |
50 |
$22.13 |
| 71046 |
Radiologic examination, chest; 2 views |
86 |
86 |
$18.68 |
| 86200 |
|
233 |
231 |
$18.63 |
| 88142 |
|
231 |
231 |
$18.13 |
| 84403 |
|
162 |
162 |
$18.06 |
| 90688 |
|
59 |
59 |
$18.00 |
| 83002 |
|
226 |
226 |
$17.97 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
62 |
62 |
$17.68 |
| 86225 |
|
171 |
171 |
$14.44 |
| 86376 |
|
339 |
339 |
$12.80 |
| 86708 |
|
702 |
700 |
$10.90 |
| 85379 |
|
12 |
12 |
$10.86 |
| 82565 |
|
110 |
110 |
$10.24 |
| 90649 |
|
13 |
13 |
$9.00 |
| 3075F |
|
190 |
179 |
$8.08 |
| 84480 |
|
741 |
736 |
$7.00 |
| 82947 |
|
236 |
236 |
$6.54 |
| 82670 |
|
93 |
93 |
$5.00 |
| 84460 |
|
44 |
44 |
$4.58 |
| 85014 |
|
147 |
144 |
$3.75 |
| 82950 |
|
316 |
313 |
$3.04 |
| 84146 |
|
201 |
197 |
$3.00 |
| 80051 |
|
41 |
41 |
$1.24 |
| 1000F |
|
3,521 |
3,317 |
$0.00 |
| 96156 |
|
787 |
772 |
$0.00 |
| 87147 |
|
146 |
143 |
$0.00 |
| 86160 |
|
74 |
74 |
$0.00 |
| 86769 |
|
30 |
30 |
$0.00 |
| 1170F |
|
125 |
123 |
$0.00 |
| 82952 |
|
12 |
12 |
$0.00 |
| 1126F |
|
225 |
202 |
$0.00 |
| 94760 |
|
851 |
804 |
$0.00 |
| S9452 |
Nutrition classes, non-physician provider, per session |
184 |
176 |
$0.00 |
| 80081 |
|
201 |
200 |
$0.00 |
| 86593 |
|
43 |
41 |
$0.00 |
| 99058 |
|
65 |
54 |
$0.00 |
| 99443 |
|
374 |
351 |
$0.00 |
| 86695 |
|
253 |
252 |
$0.00 |
| 99441 |
|
321 |
310 |
$0.00 |
| 1125F |
|
78 |
73 |
$0.00 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
96 |
96 |
$0.00 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
255 |
255 |
$0.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
160 |
160 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
12 |
12 |
$0.00 |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
60 |
58 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
119 |
112 |
$0.00 |
| 0012A |
|
137 |
137 |
$0.00 |
| 94200 |
|
96 |
91 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
26 |
26 |
$0.00 |
| 88141 |
|
104 |
104 |
$0.00 |
| 0011A |
|
97 |
97 |
$0.00 |
| 83014 |
|
27 |
27 |
$0.00 |
| 2000F |
|
12 |
12 |
$0.00 |
| 86800 |
|
123 |
123 |
$0.00 |
| 97113 |
|
39 |
14 |
$0.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$0.00 |
| 1034F |
|
29 |
25 |
$0.00 |
| 82962 |
|
15 |
12 |
$0.00 |
| 86780 |
|
29 |
29 |
$0.00 |
| S9451 |
Exercise classes, non-physician provider, per session |
59 |
56 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
69 |
66 |
$0.00 |
| 0001A |
|
42 |
42 |
$0.00 |
| 99406 |
|
30 |
26 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
26 |
26 |
$0.00 |
| 95115 |
|
19 |
18 |
$0.00 |
| 3044F |
|
15 |
13 |
$0.00 |
| 86762 |
|
15 |
15 |
$0.00 |
| 82951 |
|
12 |
12 |
$0.00 |
| 90698 |
|
12 |
12 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
13 |
12 |
$0.00 |
| 91301 |
|
34 |
31 |
$0.00 |
| 84520 |
|
74 |
69 |
$0.00 |
| 76642 |
|
130 |
129 |
$0.00 |
| 1090F |
|
148 |
145 |
$0.00 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
135 |
128 |
$0.00 |
| 99001 |
|
130 |
117 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
165 |
160 |
$0.00 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
360 |
298 |
$0.00 |
| A4550 |
Surgical trays |
43 |
43 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,015 |
1,015 |
$0.00 |
| 82274 |
|
592 |
569 |
$0.00 |
| 83013 |
|
277 |
276 |
$0.00 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
523 |
493 |
$0.00 |
| 1159F |
|
1,296 |
1,173 |
$0.00 |
| 98960 |
|
214 |
205 |
$0.00 |
| 96160 |
|
25 |
25 |
$0.00 |
| 99072 |
|
103 |
87 |
$0.00 |
| 82085 |
|
29 |
29 |
$0.00 |
| 87799 |
|
268 |
263 |
$0.00 |
| 82652 |
|
672 |
670 |
$0.00 |
| 84450 |
|
14 |
14 |
$0.00 |
| 99201 |
|
72 |
37 |
$0.00 |
| 87512 |
|
255 |
255 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
323 |
320 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
121 |
113 |
$0.00 |
| 2014F |
|
40 |
40 |
$0.00 |
| 86318 |
|
55 |
54 |
$0.00 |
| 83970 |
|
85 |
84 |
$0.00 |
| G9920 |
Screening performed and negative |
151 |
151 |
$0.00 |
| 3046F |
|
79 |
55 |
$0.00 |
| 86696 |
|
251 |
250 |
$0.00 |
| 36425 |
|
69 |
67 |
$0.00 |
| 83516 |
|
29 |
29 |
$0.00 |
| 99490 |
Ccm add 20min |
12 |
12 |
$0.00 |
| 82465 |
|
12 |
12 |
$0.00 |
| 83525 |
|
17 |
17 |
$0.00 |
| 0002A |
|
41 |
41 |
$0.00 |
| 3725F |
|
59 |
59 |
$0.00 |
| S9470 |
Nutritional counseling, dietitian visit |
43 |
40 |
$0.00 |
| 86790 |
|
16 |
16 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$0.00 |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
17 |
17 |
$0.00 |